These splicing events are directly regulated by MBNL1, and several of them have been linked to clinically relevant phenotypes in DM1, such as reduced dorsiflexion strength, impaired Ca2+ homeostasis, and insulin resistance in DM1 patients.13 Here, MBNL1 is linked to myotonic dystrophy type 1.